Spotlight Pathology
10 known investors
Find your way into Spotlight Pathology
Sign up to see every warm intro you have to Spotlight Pathology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Spotlight Pathology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Spotlight Pathology develops AI-based diagnostic tools for pathology, particularly focused on blood cancer diagnosis and digital pathology services. The company serves diagnostic laboratories and healthcare centers by providing decision support systems underpinned by machine learning algorithms for image analysis.
Founders & leadership

Investors · 10
How we know: Deepbridge Capital's portfolio page · medilink.co.uk · Not right? Tell us
How we know: UK Innovation & Science Seed Fund's portfolio page · Not right? Tell us
How we know: funding news · itbrief.co.uk · Not right? Tell us
Also in the syndicate · 6
Funding
SEC filings, press & company announcements- Undisclosed amountseed fundingMar 2026
Liverpool City Region Seed Fund (lead), UK Innovation and Science Seed Fund (lead), AXM Venture Capital, Deepbridge, EHE Ventures, Future Planet Capital, Lyva Labs, River Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Companies House · registry record
View on Companies House ↗- Registered name
- SPOTLIGHT PATHOLOGY LTD
- Company number
- 12435884
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 31 Jan 2020
- Registered office
- The Innovation Centre, Sci-Tech Daresbury Keckwick Lane, Daresbury, Warrington, Cheshire, WA4 4FS
- Nature of business (SIC)
- 62012 — Business and domestic software development
- Accounts
- last made up to 31 Jan 2025 · next due 31 Oct 2026
- Confirmation statement
- last made up to 30 Jan 2026 · next due 13 Feb 2027
Current officers · 5
- Richard John Byers — director, appointed 13 Oct 2021
- Martin Paul Fergie — director, appointed 31 Jan 2020
- Marcel Gehrung — director, appointed 30 Jan 2026
- Samantha Jane Perona — director, appointed 30 Jan 2026
- Andrew Edward Round — director, appointed 30 Jan 2026
Source: Companies House public register · retrieved 16 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Spotlight Pathology do?
- Spotlight Pathology develops AI-based diagnostic tools for pathology, particularly focused on blood cancer diagnosis and digital pathology services. The company serves diagnostic laboratories and healthcare centers by providing decision support systems underpinned by machine learning algorithms for image analysis.
- Who founded Spotlight Pathology?
- Spotlight Pathology was founded by Martin, Richard.
- Who are Spotlight Pathology's investors?
- Spotlight Pathology's investors include Deepbridge Capital, UK Innovation & Science Seed Fund, Future Planet Capital, River Capital.

